FDA Adverse Event
Injury
Summary report: N
STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 10 X 10, FIRM
MDR report key: 11998904
·
Received June 15, 2021
Report
- Report Number
- 1000306051-2021-03006
- Event Type
- Injury
- Date Received
- June 15, 2021
- Date of Event
- February 3, 2014
- Product Code
- FTM
- PMA / PMN Number
- K070560
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- 003
Narratives
Additional Manufacturer Narrative · 1
QA INVESTIGATION INTO LOT S11025 RESULTED IN NO REMARKABLE FINDINGS AND NO DEVIATIONS AND NO NONCONFROMANCES REVEALED. 305 DEVICES WERE RELEASED TO FINISHED GOODS. 187 REPORTED AS IMPLANTED 305 HAVE BEEN DISTRIBUTED. NO OTHER COMPLAINTS AGAINST. LOT S11025 WERE REVEALED. LOT S11025 WAS ASEPTICALLY PROCESSED, TERMINALLY STERILIZED AND MET ALL QC RELEASE CRITERIA.
Description of Event or Problem · 1
PATIENT REPRESENTATIVE REPORTED A FEMALE PATIENT HAD STRATTICE, 1010002, IMPLANTED ON (B)(6) 2012 FOR A VENTRAL HERNIA REPAIR. TWO YEARS LATER, (B)(6) 2014, PATIENT RETURNED TO HOSPITAL AND DIAGNOSED WITH INCISIONAL HERNIA. STRATTICE MESH REMOVED AT THAT TIME. LOT# S11025-135.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 899403 | STRATTICE RECONSTRUCTIVE TISSUE MATRIX, 10 X 10, FIRM | MESH, SURGICAL | FTM | S11025 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |